The assay is fast and simple and has already shown clinical utility, although its interpretation may be limited by reference ...

A new method vastly improves on the existing approach for single-cell genetic sequencing, enabling scientists to read the genomes of individual cells and viral particles in the environment more ...

Waters Corp reports record Q3 2025 sales and profit growth, raises full-year guidance, and highlights new product launches and BD deal synergies.

Minimal residual disease (MRD)-guided retreatment with anti-CD20 antibodies effectively lowers MRD levels and delays clinical relapse in patients with high-risk chronic lymphocytic leukemia (CLL), ...

A lower number of CD26+ LSCs at diagnosis correlates with optimal molecular response in CML patients at 3, 12, and 24 months.

Standard Biotools Inc ( ($LAB) ) has released its Q3 earnings. Here is a breakdown of the information Standard Biotools Inc presented to its ...

Invited presentation followed by panel discussion on the next wave of innovation in immunotherapy of cancer: Paul Peter Tak, M.D., Ph.D., ...

SAN ANTONIO, November 05, 2025--bioAffinity Technologies announced the volume of CyPath® Lung tests processed in October ...

New research has updated the understanding of how sugars, known as glycans, help immune cells move into the skin in the ...

A University of Alberta research team has discovered a new function for brain molecules known as gangliosides, offering ...